KRAS and neoplasm: The correlation analysis included the following clinical–pathological variables: sex, ECOG PS, age, number of metastatic sites, tumor grading, lung metastasis, liver metastasis, body mass index, primary tumor location, K-RAS mutational status, serum blood CEA concentration, and number of previous lines of systemic therapies in the overall patient cohort (Table S2).